Dr. Myzak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Sidney Kimmel Comprehensive Cancer Center
Rochester, MN 55905Phone+1 410-614-4459
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2010 - 2013
University of Vermont College of MedicineClass of 2010
Certifications & Licensure
MN State Medical License 2016 - 2020
MD State Medical License 2013 - 2017
OR State Medical License 2012 - 2015
Publications & Presentations
PubMed
- 24 citationsMyeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acidMelinda C. Myzak, Anitra C. Carr
Redox Report. 2002-01-01 - 214 citationsSulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cellsMelinda C. Myzak, Karin Hardin, Rong Wang, Roderick H. Dashwood, Emily Ho
Carcinogenesis. 2006-04-01 - 364 citationsA Novel Mechanism of Chemoprotection by Sulforaphane: Inhibition of Histone DeacetylaseMelinda C. Myzak, P. Andrew Karplus, Fung-Lung Chung, Roderick H. Dashwood
Cancer Research. 2004-08-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
